China Resources Pharmaceutical Group Limited
China Resources Pharmaceutical Group Limited (3320.HK) Stock Technical Analysis & Trading Signals
Live technical indicators, trading signals, and momentum insights for China Resources Pharmaceutical Group Limited (HKSE:3320.HK).
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer3320.HK Technical Analysis Summary
China Resources Pharmaceutical Group Limited stock currently trades in a neutral range, with no clear dominance from buyers or sellers.
Technical conditions suggest China Resources Pharmaceutical Group Limited is consolidating, awaiting a decisive move.
RSI (14): 37.31
Stochastic %K: 5.71
Williams %R: -97.06
Rate of Change (ROC): -15.70
Takeaway:China Resources Pharmaceutical Group Limited shows strong bearish momentum, signaling downside pressure.
MACD: 0.13
ADX: 40.25
ATR (14): 0.22
CCI (14): -197.45
Takeaway:China Resources Pharmaceutical Group Limited shows a firm trend supported by momentum, though one signal suggests caution.
Takeaway:China Resources Pharmaceutical Group Limited trades near the lower band, signaling oversold conditions and potential rebound.
Takeaway:China Resources Pharmaceutical Group Limited trades near the lower channel, signaling strong support and possible rebound.
Overall Takeaway:3320.HK shows bearish money flow, with sellers dominating volume and vigor.
Bullish Signals
MACD above 0 → bullish trend confirmation.
ADX above 20 → strong underlying trend.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Technical indicators for China Resources Pharmaceutical Group Limited are mixed, suggesting a Hold or wait-and-see approach.